Registry for advanced endoscopic procedures
Official title: Advanced Endo-therapeutic Procedure : Registry-based Observational Study
Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT04117100 · Data updated 2026-11-12
This study is collecting information from patients who are having advanced endoscopy procedures for gastrointestinal diseases to see how well these treatments work and improve patient care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | June 13, 2018 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT04117100 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are scheduled for elective advanced therapeutic endoscopy procedures.
✕Probably not a fit
Patients with coagulopathy, poor general health, or those unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on advanced therapeutic endoscopy procedures aimed at treating gastrointestinal diseases such as Zenker diverticulum, polyps of the colon, and colorectal cancer. Conducted at the Centre Hospitalier de l'Université de Montréal, the study aims to improve the quality of advanced endotherapeutic practices by collecting and analyzing data from patients undergoing procedures like endoscopic mucosal resection and per oral endoscopic myotomy. The data will be gathered prospectively and stored in a secure electronic registry to assess the effectiveness and quality of these minimally invasive treatments.
Why it matters
Potential benefit: If successful, this study could enhance the quality and accessibility of minimally invasive treatments for gastrointestinal diseases.
How similar studies have gone: Other studies have shown promising results with advanced endoscopic techniques, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years * Presenting for an elective advanced therapeutic endoscopy (ESD, EMR, advanced polypectomy, POEM or Zenker treatment) * Signed informed consent form Exclusion Criteria: * Patients that are not capable understanding the trial and patients without consent. * Patients with coagulopathy * Patient with poor general health defined as an American Society of Anesthesiologists class greater than three * Pregnancy
Where it's running
-
Centre Hospitalier Universitaire de Montréal (CHUM)
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Daniel von Renteln, MD,PhD — Centre Hospitalier Universitaire de Montréal (CHUM)
- Study coordinator: Daniel von Renteln, MD, PhD
- Email: daniel.von.renteln.med@ssss.gouv.qc.ca
- Phone: 514-890-8000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Laser-based sizing of GI lesions during endoscopies
This study tests whether the AccuMeasure laser tool gives more accurate and reliable lesion size measurements during colonoscopies for adults with colon polyps or Crohn’s disease than traditional endoscopic estimates.
-
Prehabilitation before high-risk cancer surgery
This trial tests a multidisciplinary prehabilitation program to see if it helps adults with cancer recover better after major abdominal surgery.
-
Personal cancer risk testing using genetic, blood, and tumor monitoring
This project will test whether combining genetic testing, blood-based analyses, and tumor tissue checks can identify personal cancer risk and detect early recurrence in adults with breast, ovarian, colorectal, melanoma, or certain non-small cell lung cancers.
-
Liquid biopsy and machine learning to detect early colorectal cancer, advanced adenomas, Lynch-related cancers, and residual disease
This project will test a blood-based liquid biopsy that uses microRNA signals and machine learning to detect colorectal cancer, advanced adenomas, Lynch-associated cancers, and molecular residual disease in people who have a colonoscopy.
-
Colorectal Cancer Screening Outreach for Better Adherence
This trial tests a bundled messaging approach to help adults at risk complete colorectal cancer screening.
-
Blood-based delta-HLD methylation test for detecting colorectal cancer
This will try a blood-based delta-HLD methylation test to see if it can detect colorectal cancer in people scheduled for colonoscopy or colorectal surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.